| Ticagrelor in patients with stable coronary disease and diabetes PG Steg, DL Bhatt, T Simon, K Fox, SR Mehta, RA Harrington, C Held, ... New England journal of medicine 381 (14), 1309-1320, 2019 | 333 | 2019 |
| Brigatinib versus crizotinib in ALK inhibitor–naive advanced ALK-positive NSCLC: final results of phase 3 ALTA-1L trial DR Camidge, HR Kim, MJ Ahn, JCH Yang, JY Han, MJ Hochmair, KH Lee, ... Journal of Thoracic Oncology 16 (12), 2091-2108, 2021 | 219 | 2021 |
| Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography HK Gaggin, Y Liu, A Lyass, RR van Kimmenade, SR Motiwala, N Kelly, ... Circulation 135, 116-127, 2016 | 120 | 2016 |
| Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease: insights from Getting to an Improved … SV Arnold, JA De Lemos, RS Rosenson, CM Ballantyne, Y Liu, KE Mues, ... Circulation 140 (7), 618-620, 2019 | 119 | 2019 |
| Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US CP Cannon, JA De Lemos, RS Rosenson, CM Ballantyne, Y Liu, Q Gao, ... JAMA cardiology 6 (9), 1060-1068, 2021 | 100 | 2021 |
| Proton-pump inhibitors reduce gastrointestinal events regardless of aspirin dose in patients requiring dual antiplatelet therapy M Vaduganathan, DL Bhatt, BL Cryer, Y Liu, WH Hsieh, G Doros, ... Journal of the American College of Cardiology 67 (14), 1661-1671, 2016 | 93 | 2016 |
| Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndromes: the EXAMINE trial SR Heller, RM Bergenstal, WB White, S Kupfer, GL Bakris, WC Cushman, ... Diabetes, Obesity and Metabolism 19 (5), 664-671, 2017 | 61 | 2017 |
| Circulating proneurotensin concentrations and cardiovascular disease events in the community: the Framingham Heart Study JL Januzzi Jr, A Lyass, Y Liu, H Gaggin, A Trebnick, AS Maisel, ... Arteriosclerosis, thrombosis, and vascular biology 36 (8), 1692-1697, 2016 | 61 | 2016 |
| 12-month results from the unblinded phase of the RADIANCE-HTN SOLO trial of ultrasound renal denervation M Azizi, J Daemen, MD Lobo, F Mahfoud, ASP Sharp, RE Schmieder, ... Cardiovascular Interventions 13 (24), 2922-2933, 2020 | 56 | 2020 |
| Efficacy and safety of proton-pump inhibitors in high-risk cardiovascular subsets of the COGENT trial M Vaduganathan, CP Cannon, BL Cryer, Y Liu, WH Hsieh, G Doros, ... The American journal of medicine 129 (9), 1002-1005, 2016 | 55 | 2016 |
| Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial BA Bergmark, CP Cannon, WB White, P Jarolim, Y Liu, MP Bonaca, ... Diabetes, Obesity and Metabolism 19 (7), 962-969, 2017 | 39 | 2017 |
| Clinical and biomarker predictors of expanded heart failure outcomes in patients with type 2 diabetes mellitus after a recent acute coronary syndrome: insights from the EXAMINE … A Sharma, M Vaduganathan, JP Ferreira, Y Liu, GL Bakris, CP Cannon, ... Journal of the American Heart Association 9 (1), e012797, 2020 | 36 | 2020 |
| High‐sensitivity C‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of … YC Hwang, DA Morrow, CP Cannon, Y Liu, R Bergenstal, S Heller, ... Diabetes, Obesity and Metabolism 20 (3), 654-659, 2018 | 33 | 2018 |
| Impact of clopidogrel therapy on mortality and cancer in patients with cardiovascular and cerebrovascular disease: a patient-level meta-analysis S Elmariah, G Doros, OR Benavente, DL Bhatt, SJ Connolly, S Yusuf, ... Circulation: Cardiovascular Interventions 11 (1), e005795, 2018 | 27 | 2018 |
| Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular … CP Cannon, JA de Lemos, RS Rosenson, CM Ballantyne, Y Liu, D Yazdi, ... American heart journal 219, 70-77, 2020 | 25 | 2020 |
| Average clinician‐measured blood pressures and cardiovascular outcomes in patients with type 2 diabetes mellitus and ischemic heart disease in the Examine trial WB White, F Jalil, WC Cushman, GL Bakris, R Bergenstal, SR Heller, ... Journal of the American Heart Association 7 (20), e009114, 2018 | 23 | 2018 |
| Association of insurance type with receipt of oral anticoagulation in insured patients with atrial fibrillation: A report from the American College of Cardiology NCDR PINNACLE … CM Yong, Y Liu, P Apruzzese, G Doros, CP Cannon, TM Maddox, A Gehi, ... American heart journal 195, 50-59, 2018 | 20 | 2018 |
| Ambulatory blood pressure monitoring to predict response to renal denervation: a post hoc analysis of the RADIANCE-HTN SOLO study P Gosse, A Cremer, AJ Kirtane, MD Lobo, M Saxena, J Daemen, Y Wang, ... Hypertension 77 (2), 529-536, 2021 | 19 | 2021 |
| Diabetes-related factors and the effects of ticagrelor plus aspirin in the THEMIS and THEMIS-PCI trials LA Leiter, DL Bhatt, DK McGuire, H Teoh, K Fox, T Simon, SR Mehta, ... Journal of the American College of Cardiology 77 (19), 2366-2377, 2021 | 15 | 2021 |
| Early and chronic dipeptidyl‐peptidase‐IV inhibition and cardiovascular events in patients with type 2 diabetes mellitus after an acute coronary syndrome: a landmark analysis … A Sharma, CP Cannon, WB White, Y Liu, GL Bakris, WC Cushman, ... Journal of the American Heart Association 7 (11), e007649, 2018 | 14 | 2018 |
Lanyu LeiManager of Biostatistics, Harvard Clinical Research InstituteVerified email at hcri.harvard.edu
Lanyu LeiManager of Biostatistics, Harvard Clinical Research InstituteVerified email at hcri.harvard.edu